NCT04530461 Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases Status UNKNOWN Phase N/A
NCT04440566 O-GlcNAcylation Role in the Pathophysiology of Systemic Lupus Erythematosus Status COMPLETED Phase NA
NCT04433585 A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE) Status COMPLETED Phase PHASE2
NCT04431167 Healthy Lifestyle Intervention in Patients with Systemic Lupus Erythematosus: the Living Well with Lupus Study Status COMPLETED Phase NA
NCT04411407 PROM Collected Via a WebApp Versus a Touch Screen Solution Among Patients With SLE Status COMPLETED Phase NA
NCT04397237 Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in Europe Status UNKNOWN Phase N/A
NCT04397107 The Therapeutic Value and Mechanism of Recombinant Human Interleukin-2 on Children With Rheumatic Diseases Status COMPLETED Phase NA
NCT04356014 Telangiectatic Palmoplantar Keratoderma in Systemic and Subacute Lupus Erythematosus Status UNKNOWN Phase N/A
NCT04345159 Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease Status COMPLETED Phase N/A
NCT04335747 COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases Status TERMINATED Phase N/A
NCT04335643 Telehealth CBT for Adolescents and Young Adults With Childhood-onset Systemic Lupus Erythematosus Status COMPLETED Phase NA